Treatment with recombinant IL-2 or IFN-γ increased NK cell function and activity; however, the cytotoxic activity of NK cells isolated from HCC patients against target cells remains lower compared to patients suffering from other liver-related diseases [132]. Here, IFNG is linked to hepatocellular carcinoma.